Absorption and disposition kinetics of lithium carbonate following administration of conventional and controlled release formulations
Author
dc.contributor.author
Arancibia,
Author
dc.contributor.author
Corvalan,
Author
dc.contributor.author
Mella,
Author
dc.contributor.author
Concha,
Admission date
dc.date.accessioned
2018-12-20T15:05:09Z
Available date
dc.date.available
2018-12-20T15:05:09Z
Publication date
dc.date.issued
1986
Cita de ítem
dc.identifier.citation
International Journal of Clinical Pharmacology Therapy and Toxicology, Volumen 24, Issue 5, 2018, Pages 240-245
Identifier
dc.identifier.issn
01744879
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/157688
Abstract
dc.description.abstract
The absorption and disposition kinetics of lithium carbonate administered to eight healthy volunteers in two dosage forms were studied. A conventional immediate release tablet and a controlled release preparation, developed in our laboratory and containing the drug into a hydrophilic matrix, were employed in the study. Lithium carbonate confers upon the body the distinct characteristics of a two-compartment open model with a mean slow disposition rate constant (β) of 0.0435 h-1 ± 0.0086 SD, corresponding to a mean biological half-life of 16.49 ± 2.95 SD. The mean half-life of the distributory α-phase was 1.40 ± 0.27 SD. The apparent volume of distribution (Vd(area)) was 0.539 1 kg-1 ± 0.130 SD and the volume of the central compartment (V1) was 0.224 l/kg-1 ± 0.066 SD, about one half that of the volume at steady state (Vd(ss)) which was 0.455 l/kg-1 ± 0.106 SD. Total body clearance (Cl(B)) was 0.0241 l/kg-1 h ± 0.0102 SD. The administration of the controlled release preparations to the